Misty Coleman
Psychiatric/Mental Health · Lexington, KYNPI 1730946385
Payments from drug & device makers
Across 123 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$300
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$296
- Otsuka America Pharmaceutical, Inc.$269
- Supernus Pharmaceuticals, Inc.$140
- Alkermes, Inc.$124
- Corium, LLC$120
- plus $590 from 11 others
What the payments were for
- Food & beverage$1,838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $296 |
| Otsuka America Pharmaceutical, Inc. | 15 | $269 |
| Supernus Pharmaceuticals, Inc. | 10 | $140 |
| Alkermes, Inc. | 5 | $124 |
| Corium, LLC | 7 | $120 |
| Johnson & Johnson | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| E.r. Squibb & Sons, L.L.C. | 4 | $76 |
| Neurocrine Biosciences, Inc. | 3 | $71 |
| Lundbeck LLC | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Indivior Inc. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Biogen | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $23 |
How this compares
$1,838 in reported general payments places this provider in the 70th percentile of 946 psychiatric/mental health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 12 | $64 |
| Clonazepam | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Lexington
- Adam LooseLexington$44K
- Lauren WilliamsLexington$40K
- Laura ThomsonLexington$25K
- Laura WeddleLexington$15K
- Latoya LeeLexington$12K
- Isabel JonesLexington$9K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.